Isolation and identification of human influenza viruses in cell culture: summary analysis of the WHO external quality assessment programme for National Influenza Centres in the WHO regions of the Americas, Africa and Eastern Mediterranean, 2017

Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014

WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013

Members of the Western Pacific Region Global Influenza Surveillance and Response System, this included contributing authors from WHO Collaborating Centre for Reference and Research on Influenza, Melbourne: Barr IG, Hurt AC, Kelso A, Reading P and Sullivan S

Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region

WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011

Absence of cross-reactive antibodies to influenza
A (H1N1) 2009 before and after vaccination with 2009 Southern
Hemisphere seasonal trivalent influenza vaccine in children aged
6 months-9 years: a prospective study

Epidemiological, antigenic and genetic characteristics
of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses:
basis for the WHO recommendation on the composition of influenza
vaccines for use in the 2009-2010 Northern Hemisphere season